Article History
Received: 30 March 2023
Accepted: 18 October 2023
First Online: 8 November 2023
Declarations
:
: The approval for this study was waived to ensure that this study respects patient’s confidentiality and anonymity. Reference 2022–0804. Date: 16-August-2022.The membership of the institutional review board complies with the membership requirements in the US Code of Federal Regulations (21CFR56 and 45CFR46) of the Food and Drug Administration.
: Not applicable.
: The authors declare that they have no competing interests.